What does VALUE stand for?

Valsartan Antihypertensive Long-term Use Evaluation (hypertension)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Valley Association of Language Teachers Vegas Alternative (New Zealand) Virtual Action Learning Team VTOL Approach & Landing Technology VTOL Automatic Landing Technology Violence And Learning: Taking Action Virginia Association of Local Tax Auditors (Chesterfield, VA) Vulnerability and Lethality Testing System Vector Arithmetic Logic Unit Valorisation et Utilisation pour l'Europe (French, programme for dissemination and utilisation of research results)		Vision and Leadership Uniting Education (Pennsylvania; est. 1989) VLF Ashore Lifetime Upkeep Effort Voice for Adult Literacy United for Education (Media, PA) Volcano Analysis and Visualization Environment (Hawaiian Volcano Observatory) Virginia Association of Licensed Veterinary Technicians Attack Squadron, Medium Migraine Associated Vertigo Vacuum Advance Mechanism Value Added Manufacturing Value Approximation Method (baseball statistical analysis)

Samples in periodicals archive:

In the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study, and Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial, the "winning" strategy for CV protection was the one backed by the trial's commercial sponsors--and also the one that resulted in significantly lower blood pressure than the comparator, he said.

Class of antihypertensive unimportant if it works

Trial cites benefits of Diovan Novartis (Basel, Switzerland) reported at last months European Meeting on Hypertension the results of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial, a randomized, active-controlled study conducted at 934 clinical sites in 31 countries.

Report from Europe

DETROIT -- The efficacy of calcium channel blockers for the treatment of hypertension in African Americans was confirmed in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.

Trial confirms value of CCBs in black patients

The Diovan clinical trial program includes more than 35,000 patients and is anchored by three major morbidity and mortality trials: the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial involving approximately 14,000 high-risk hypertensive patients; the Valsartan Heart Failure Trial (Val-HeFT) in approximately 5,000 congestive heart failure patients; and the Valsartan in Acute Myocardial Infarction (VALIANT) trial in approximately 14,500 patients who have recently suffered a heart attack.

New Study Shows Diovan(R) (Valsartan) Reduces Left Ventricular ...

Novartis has three morbidity and mortality trials underway with Diovan: The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial involving approximately 14,000 high-risk hypertensive patients; the Valsartan Heart Failure Trial (Val-HeFT) in approximately 5,000 congestive heart failure patients; and the Valsartan In Acute Myocardial Infarction (VALIANT) trial with 14,500 patients who have recently suffered a heart attack.

Novartis Pharmaceuticals Corporation Statement: